-
There is a shortage of some APIs in the US and India
On March 11, a heavy news broke out. Foreign media sources said that the US FDA said on March 10 (Tuesday) that it would delay the review of almost al...
2020-07-01 16:41 -
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
On 9 June , U.S. time, Eli Lilly (NYSE: LLY) announced that its GLP-1 and GIP dual receptor agonist Tirzepatide (TZP) phase III clinical trial of the ...
2020-06-30 15:26 -
WuXi NextCODE rebrands as Genuity Science, sheds Shanghai operations
Genomics informatics and sequencing service giant WuXi NextCODE is rebranding itself as Genuity Science.
2020-06-28 18:04 -
Study is first to identify potential therapeutic targets for COVID-19
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19. By s...
2020-06-28 17:59 -
Japanese University uses silkworm to make candidate protein for COVID-19 vaccine
On the 26th, the insect genomics research team led by Professor Hirosaki and others from Kyushu University, Japan, announced that they had successfull...
2020-06-28 14:27 -
Gadot will expand the application of magnesium citrate
Israeli ingredient and fine chemical product supplier Gadot Biochemical Industries recently announced that after successfully launching Chewable Zinc ...
2020-06-23 10:05 -
Sanofi plans €610m vaccines investment to raise pandemic readiness
Funds will be split between a production unit and a new vaccine development centre
2020-06-22 15:03 -
Hikal: Successfully developed Fapiravir APIs and intermediates
Indian pharmaceutical intermediate and API manufacturer Hikal Limited (Hikal Limited) announced on June 19 that it has successfully developed Favipira...
2020-06-22 09:12 -
Niuhuang Jiedu tablets, anti-viral oral liquid and other drugs were inspected
On June 12, the Zhejiang Provincial Food and Drug Administration issued the first phase of the 2020 Zhejiang Province Drug Quality Inspection and Anno...
2020-06-19 15:32 -
Analysis of Hot Varieties in Antiviral Raw Material Market
my country's antiviral APIs are small-scale varieties in the entire category of materials and have been developing steadily in recent years.
2020-06-19 10:02
Hot News
- ECHEMI High Quality Inquiries ... Apr 10, 2024
- Due to environmental policies ... Mar 29, 2024
- Evonik strengthens its biosolu... Apr 10, 2024
- DSM Firmenich partners with st... Mar 29, 2024
- Symrise-led joint venture to m... Mar 29, 2024
Related Products